Recent Advances in Diagnosing Chronic Pulmonary Aspergillosis

Recent Advances in Diagnosing Chronic Pulmonary Aspergillosis

Purpose: The diagnosis of chronic pulmonary aspergillosis (CPA) is occasionally complicated due to poor sensitivity of mycological culture and colonization of Aspergillus species in the airway. Several diagnostic methods have been developed for the diagnosis of invasive pulmonary aspergillosis; howe...

Full description

Bibliographic Details
Main Authors:	Takahiro Takazono, Koichi Izumikawa
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2018-08-01
Series:	Frontiers in Microbiology
Subjects:	aspergillosis Aspergillus galactomannan Aspergillus IgG antibody azole resistance
Online Access:	https://www.frontiersin.org/article/10.3389/fmicb.2018.01810/full

Similar Items

Diagnostic value of BALF-GM combined with Aspergillus IgG and IgM in chronic pulmonary aspergillosis
by: Li Tianyi, Tang Chunmei, Xiao Haihao, Zhang Yanbin, Su Wenjie
Published: (2022-03-01)

Validity of Platelia Aspergillus IgG and Aspergillus Precipitin Test To Distinguish Pulmonary Aspergillosis from Colonization
by: Kyota Shinfuku, et al.
Published: (2023-02-01)

Seroprevalence and prognostic value of Aspergillus-specific IgG among non-neutropenic invasive pulmonary aspergillosis patients: a prospective multicenter study
by: Meng-Rui Lee, et al.
Published: (2024-11-01)

Chronic cavitary pulmonary aspergillosis in an immunocompetent child
by: Adeyinka A. Davies, et al.
Published: (2022-09-01)

Diagnostic Laboratory Features and Performance of an Aspergillus IgG Lateral Flow Assay in a Chronic Pulmonary Aspergillosis Cohort
by: Rong-Sheng Zhu, et al.
Published: (2023-06-01)

Potential value of serum Aspergillus IgG antibody detection in the diagnosis of invasive and chronic pulmonary aspergillosis in non-agranulocytic patients
by: Qihong Yu, et al.
Published: (2020-04-01)

Sputum Galactomannan Has Utility in the Diagnosis of Chronic Pulmonary Aspergillosis
by: Ali Nuh, et al.
Published: (2022-02-01)

Invasive pulmonary aspergillosis: the state of art and the clinical case.
by: K. Yu. Gashynova, et al.
Published: (2018-04-01)

Efficacy of LD Bio <i>Aspergillus</i> ICT Lateral Flow Assay for Serodiagnosis of Chronic Pulmonary Aspergillosis
by: Animesh Ray, et al.
Published: (2022-04-01)

<i>Aspergillus fumigatus</i> and <i>Aspergillus flavus</i>-Specific IgG Cut-Offs for the Diagnosis of Chronic Pulmonary Aspergillosis in Pakistan
by: Kauser Jabeen, et al.
Published: (2020-10-01)

Chronic pulmonary aspergillosis - case series and review of Indian literature
by: Vikas Marwah, et al.
Published: (2021-01-01)

Serological Changes in Anti-<i>Aspergillus</i> IgG Antibody and Development of Chronic Pulmonary Aspergillosis in Patients Treated for Pulmonary Tuberculosis
by: Changwhan Kim, et al.
Published: (2022-01-01)

The Association of Chronic Pulmonary Aspergillosis and Chronic Pulmonary Histoplasmosis with MDR-TB Patients in Indonesia
by: Noni N. Soeroso, et al.
Published: (2024-07-01)

Detection of laboratory biomarkes in haematological and pulmonology patients at high risk for aspergillosis
by: Ratkov Eleonora, et al.
Published: (2012-01-01)

Comparison of Aspergillus-specific antibody cut-offs for the diagnosis of aspergillosis
by: Chien-Wen Hsiao, et al.
Published: (2022-12-01)

Evaluation of the Dynamiker Quantitative Anti-Aspergillus Fumigatus Specific Detection for the Diagnosis of Different Kinds of Chronic Pulmonary Aspergillosis
by: Zhu B, et al.
Published: (2024-09-01)

Microbiological Non-Culture-Based Methods for Diagnosing Invasive Pulmonary Aspergillosis in ICU Patients
by: Ulrike Scharmann, et al.
Published: (2023-08-01)

Galactomannan detection from piperacillin-tazobactam brands available in the Brazilian market
by: Melissa Orzechowski Xavier, et al.

A Laboratory-Based Study on Multiple Biomarker Testing in the Diagnosis of COVID-19-Associated Pulmonary Aspergillosis (CAPA): Real-Life Data
by: Cornelia Lass-Flörl, et al.
Published: (2022-12-01)

Serum Cytokine Biomarkers for Use in Diagnosing Pulmonary Tuberculosis versus Chronic Pulmonary Aspergillosis
by: Ren W, et al.
Published: (2023-04-01)

Outcome Analysis of Breakthrough Invasive Aspergillosis on Anti-Mold Azole Prophylaxis and Treatment: 30-Year Experience in Hematologic Malignancy Patients
by: Hiba Dagher, et al.
Published: (2025-02-01)

Establishing Aspergillus-Specific IgG Cut-Off Level for Chronic Pulmonary Aspergillosis Diagnosis: Multicenter Prospective Cohort Study
by: Meng-Rui Lee, et al.
Published: (2021-06-01)

<i>Aspergillus</i> Galactomannan Titer as a Diagnostic Marker of Invasive Pulmonary Aspergillosis in Lung Transplant Recipients: A Single-Center Retrospective Cohort Study
by: Eun-Young Kim, et al.
Published: (2023-04-01)

Clinical and Microbiological Characteristics of Culture-Positive, Influenza-Associated Pulmonary Aspergillosis: A Single-Center Study in Southern Taiwan, 2016–2019
by: Chi-Jung Wu, et al.
Published: (2022-01-01)

Azole Resistance of Aspergillus fumigatus in Immunocompromised Patients with Invasive Aspergillosis
by: Alexandre Alanio, et al.
Published: (2016-01-01)

Prognostic Scores and Azole-Resistant <i>Aspergillus fumigatus</i> in Invasive Aspergillosis from an Indian Respiratory Medicine ICU (ICU Patients with IA Suspicion)
by: Yubhisha Dabas, et al.
Published: (2021-11-01)

New clinical algorithm including fungal biomarkers to better diagnose probable invasive pulmonary aspergillosis in ICU
by: Joffrey Hamam, et al.
Published: (2021-03-01)

Aspergillus fumigatus and aspergillosis /
by: Latg,̌ Jean-Paul, 1948-, et al.
Published: (c200)

Chronic Pulmonary Aspergillosis—Where Are We? and Where Are We Going?
by: Gemma E. Hayes, et al.
Published: (2016-06-01)

Exploring the role of Aspergillus galactomannan antigen in assessing the risk factor of acute exacerbations in chronic obstructive pulmonary disease patients: a cross-sectional study
by: Jayabharathi Palanivel, et al.
Published: (2024-09-01)

Aspergillosis, Avian Species and the One Health Perspective: The Possible Importance of Birds in Azole Resistance
by: Aryse Martins Melo, et al.
Published: (2020-12-01)

COVID-19-associated pulmonary aspergillosis in intensive care unit: A real-life experience
by: Alessandro Russo, et al.
Published: (2024-01-01)

Value Evaluation of Quantitative Aspergillus fumigatus-Specific IgG Antibody Test in the Diagnosis of Non-neutropenic Invasive Pulmonary Aspergillosis
by: Sheng L, et al.
Published: (2024-05-01)

Epidemiology, Drug Susceptibility, and Clinical Risk Factors in Patients With Invasive Aspergillosis
by: Yuerong Wang, et al.
Published: (2022-04-01)

Pulmonary Aspergillosis: An Observation from a Tertiary Care Hospital of Western Uttar Pradesh
by: Zeba Naj, et al.
Published: (2024-11-01)

Tracheal Aspirate Galactomannan Testing in COVID-19-Associated Pulmonary Aspergillosis
by: Carla M. Román-Montes, et al.
Published: (2022-04-01)

Environmental Hot Spots and Resistance-Associated Application Practices for Azole-Resistant Aspergillus fumigatus, Denmark, 2020–2023
by: Maiken Cavling Arendrup, et al.
Published: (2024-08-01)

Evaluation of the LDBio ICT IgG/IgM lateral flow assay versus the Bordier Elisa assay for the diagnosis of chronic pulmonary aspergillosis in Nigeria
by: O. J. Balogun, et al.
Published: (2025-03-01)

Invasive <i>Aspergillosis</i> in the Intensive Care Unit
by: Liam Townsend, et al.
Published: (2022-11-01)

Complications of chronic necrotizing pulmonary aspergillosis: review of published case reports
by: Aleksandra Barac, et al.